MBX MBX Biosciences, Inc. - Common Stock
$68,35
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 6, 2026
52W-Spanne
$10–$73
93% of range
Analystenbewertung
BUY
15 analysts
Kursziel
$88
+29% upside
P/E (TTM)
-28.7
ROE
-29.6%
Nettogewinnmarge
—
MBX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$68.34
Marktkapitalisierung
$3.07B
P/E (TTM)
-28.7
EPS (TTM)
$-2.38
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-29.6%
Verschuldungsgrad
—
52W-Spanne
$10 – $73
MBX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
EPS
$-2.38
2023-12-31
→
2025-12-31
Freier Cashflow
$-82M
2024-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
MBX
Peer-Median
P/E (TTM)
-28.7
38.7
P/B (K/B)
8.3
3.8
Price / FCF (Kurs / FCF)
-37.5
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
MBX
Peer-Median
ROA
-26.6%
-6.4%
ROE
-29.6%
-16.8%
ROIC
-26.6%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
MBX
Peer-Median
Current Ratio (Liquiditätsgrad)
24.6
12.8
Quick Ratio
24.1
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
MBX
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
MBX
Peer-Median
MBX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
15 Analysten
- Starker Kauf 5 33,3%
- Kauf 9 60,0%
- Halten 1 6,7%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
10 Analysten · 2026-08-18
Median
$88.00
← Unter allen Zielen
$68.34
Tief
$70.00
Hoch
$121.00
Median-Ziel
$88.00
+28,8%
Mittelwert-Ziel
$88.40
+29,3%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.06%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.78 | $-0.64 | -0.14% |
| 31. März 2026 | $-0.51 | $-0.59 | 0.08% |
| 31. Dezember 2025 | $-0.49 | $-0.62 | 0.13% |
| 30. September 2025 | $-0.63 | $-0.70 | 0.07% |
| 30. Juni 2025 | $-0.58 | $-0.77 | 0.19% |
| 31. März 2025 | $-0.71 | $-0.78 | 0.07% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| MBX | $1.42B | -13.3 | — | — | -29.6% | — |
| MANE | — | — | — | — | 82.6% | — |
| ELVN | $915M | -8.4 | — | — | -21.9% | — |
| GPCR | $14.78B | -86.9 | — | — | -12.3% | — |
| OGN | $1.87B | 10.0 | -2.9% | 3.0% | 25.2% | 53.3% |
| ALMS | — | -3.4 | — | -1011.8% | -61.9% | — |
| TARS | $3.48B | -51.5 | 146.7% | -14.7% | -19.7% | — |
| SUPN | $2.86B | -73.1 | 8.6% | -5.4% | -3.6% | — |
| ATAI | $223M | -1.4 | -1.9% | -48464.0% | -83.1% | — |
| TRVI | $1.61B | -39.1 | — | — | -22.4% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| R&D Expense | $79M | $57M | $29M | |
| SG&A Expense | $19M | $11M | $7M | |
| Operating Expenses | $98M | $68M | $35M | |
| Operating Income | $-98M | $-68M | $-35M | |
| Pretax Income | $-87M | $-62M | · | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-87M | $-62M | $-33M | |
| EPS (Basic) | $-2.38 | $-5.82 | $-31.96 | |
| EPS (Diluted) | $-2.38 | $-5.82 | $-31.96 | |
| Shares (Basic) | 36,506,092 | 10,642,954 | 1,018,757 | |
| Shares (Diluted) | 36,506,092 | 10,642,954 | 1,018,757 | |
| EBITDA | $-98M | $-68M | · |
Bilanz 21
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $75M | $49M | $31M | |
| Short-term Investments | $298M | $213M | $50M | |
| Prepaid Expense | $8M | $5M | $3M | |
| Other Current Assets | $861.0K | $803.0K | $133.0K | |
| Current Assets | $382M | $267M | $83M | |
| PP&E (Net) | $3M | $1M | $439.0K | |
| PP&E (Gross) | $3M | $2M | $617.0K | |
| Accum. Depreciation | $670.0K | $422.0K | $178.0K | |
| Other Non-current Assets | $383.0K | $50.0K | $50.0K | |
| Total Assets | $385M | $269M | $84M | |
| Accounts Payable | $3M | $5M | $1M | |
| Accrued Liabilities | $12M | $6M | $2M | |
| Current Liabilities | $15M | $11M | $4M | |
| Capital Leases | $424.0K | $0 | $171.0K | |
| Total Liabilities | $16M | $11M | $4M | |
| Common Stock | $6.0K | $5.0K | $1.0K | |
| Retained Earnings | $-224M | $-138M | $-76M | |
| AOCI | $286.0K | $55.0K | $60.0K | |
| Stockholders' Equity | $369M | $257M | $-72M | |
| Liabilities + Equity | $385M | $269M | $84M | |
| Shares Outstanding | 44,927,953 | 33,421,525 | 1,257,080 |
Cashflow 9
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $9M | $5M | $2M | |
| Operating Cash Flow | $-80M | $-55M | $-32M | |
| CapEx | $2M | $874.0K | $129.0K | |
| Investing Cash Flow | $-84M | $-161M | $-31M | |
| Stock Issued | $602M | · | · | |
| Net Stock Activity | $602M | · | · | |
| Financing Cash Flow | $190M | $234M | $69M | |
| Net Change in Cash | $26M | $19M | $6M | |
| Free Cash Flow | $-82M | $-56M | · |
Rentabilität 3
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -26.6% | -35.1% | · | |
| ROE | -29.6% | -23.4% | · | |
| ROIC | -26.6% | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 24.6 | 24.2 | · | |
| Quick Ratio | 24.1 | 23.7 | · |
Bewertung (TTM) 8
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net Income TTM | $-87M | $-62M | · | |
| Market Cap | $1.42B | $616M | · | |
| P/E | -13.3 | -3.2 | · | |
| P/B | 3.8 | 2.4 | · | |
| P / Tangible Book | 3.8 | 2.4 | · | |
| P / Cash Flow | -17.7 | -11.3 | · | |
| P / FCF | -17.3 | -11.1 | · | |
| Earnings Yield | -7.5% | -31.6% | · |
Gewinn- und Verlustrechnung 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $31M | $18M | $20M | $19M | $18M | $22M | $15M | $17M | $8M | |
| SG&A Expense | $10M | $9M | $6M | $5M | $4M | $4M | $3M | $3M | $2M | |
| Operating Expenses | $41M | $27M | $26M | $24M | $22M | $27M | $19M | $20M | $10M | |
| Operating Income | $-41M | $-27M | $-26M | $-24M | $-22M | $-27M | $-19M | $-20M | $-10M | |
| Net Income | $-37M | $-24M | $-22M | $-22M | $-19M | $-24M | $-16M | $-18M | $-9M | |
| EPS (Basic) | $-0.78 | $-0.50 | $-0.46 | $-0.63 | $-0.58 | $-0.71 | $19.84 | $-2.78 | $-7.68 | |
| EPS (Diluted) | $-0.78 | $-0.50 | $-0.46 | $-0.63 | $-0.58 | $-0.71 | $19.84 | $-2.78 | $-7.68 | |
| Shares (Basic) | 47,696,363 | 46,576,204 | -64,551,276 | 34,198,597 | 33,446,385 | 33,412,386 | 1,668,393 | 6,515,616 | 41,933 | |
| Shares (Diluted) | 47,696,363 | 46,576,204 | -64,551,276 | 34,198,597 | 33,446,385 | 33,412,386 | 1,668,393 | 6,515,616 | 41,933 | |
| EBITDA | $-41M | $-27M | · | $-24M | $-22M | $-27M | · | $-20M | · |
Bilanz 21
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54M | $45M | $75M | $223M | $40M | $30M | $49M | $133M | $31M | |
| Short-term Investments | $364M | $395M | $298M | $169M | $185M | $211M | $213M | $144M | $50M | |
| Prepaid Expense | $9M | $9M | $8M | $6M | $4M | $3M | $5M | $4M | $3M | |
| Other Current Assets | $1M | $814.0K | $861.0K | $882.0K | $472.0K | $626.0K | $803.0K | $838.0K | $133.0K | |
| Current Assets | $428M | $449M | $382M | $398M | $229M | $244M | $267M | $281M | $83M | |
| PP&E (Net) | $5M | $3M | $3M | $2M | $2M | $2M | $1M | $1M | $439.0K | |
| PP&E (Gross) | $5M | $4M | $3M | $3M | $2M | $2M | $2M | $1M | $617.0K | |
| Accum. Depreciation | $813.0K | $734.0K | $670.0K | $610.0K | $560.0K | $499.0K | $422.0K | $364.0K | $178.0K | |
| Other Non-current Assets | $625.0K | $579.0K | $383.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | |
| Total Assets | $436M | $453M | $385M | $400M | $232M | $246M | $269M | $282M | $84M | |
| Accounts Payable | $4M | $7M | $3M | $4M | $6M | $4M | $5M | $5M | $1M | |
| Accrued Liabilities | $19M | $7M | $12M | $8M | $6M | $6M | $6M | $6M | $2M | |
| Current Liabilities | $24M | $15M | $15M | $12M | $12M | $10M | $11M | $11M | $4M | |
| Capital Leases | $3M | $377.0K | $424.0K | $469.0K | $512.0K | · | $0 | $44.0K | $171.0K | |
| Total Liabilities | $26M | $15M | $16M | $13M | $12M | $11M | $11M | $11M | $4M | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $1.0K | |
| Retained Earnings | $-285M | $-248M | $-224M | $-202M | $-181M | $-161M | $-138M | $-122M | $-76M | |
| AOCI | $-1M | $-606.0K | $286.0K | $154.0K | $11.0K | $53.0K | $55.0K | $106.0K | $60.0K | |
| Stockholders' Equity | $410M | $438M | $369M | $388M | $219M | $235M | $257M | $271M | $-72M | |
| Liabilities + Equity | $436M | $453M | $385M | $400M | $232M | $246M | $269M | $282M | $84M | |
| Shares Outstanding | 47,949,804 | 47,570,464 | 44,927,953 | 44,715,498 | 33,592,226 | 33,424,371 | 33,421,525 | 33,376,058 | 1,257,080 |
Cashflow 9
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $5M | $3M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Operating Cash Flow | $-23M | $-20M | $-18M | $-22M | $-17M | $-23M | $-16M | $-15M | $-11M | |
| CapEx | $901.0K | $437.0K | $793.0K | $399.0K | $707.0K | $30.0K | $92.0K | $57.0K | $55.0K | |
| Investing Cash Flow | $29M | $-97M | $-130M | $17M | $26M | $3M | $-67M | $-101M | $-29M | |
| Stock Issued | $0 | $689M | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $689M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $2M | $87M | $438.0K | $188M | $1M | $4.0K | $-132.0K | $236M | $19.0K | |
| Net Change in Cash | $9M | $-30M | $-148M | $183M | $10M | $-19M | $-84M | $120M | $-40M | |
| Free Cash Flow | · | $-21M | · | · | · | $-23M | · | · | · |
Rentabilität 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -11.1% | -6.7% | · | -6.3% | -16.8% | -19.4% | · | -12.8% | · | |
| ROE | -11.8% | -7.0% | · | -6.6% | -17.7% | -20.3% | · | -13.4% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 18.1 | 30.8 | · | 33.0 | 19.5 | 23.3 | · | 25.7 | · | |
| Quick Ratio | 17.7 | 30.2 | · | 32.5 | 19.1 | 23.0 | · | 25.4 | · |
Bewertung (TTM) 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-102M | $-88M | · | $-83M | $-77M | $-70M | · | $-56M | · | |
| Market Cap | $2.65B | $1.42B | · | $783M | $383M | $247M | · | $867M | · | |
| P/E | -22.2 | -12.3 | · | -3.7 | -0.7 | -0.3 | · | -0.7 | · | |
| P/B | 6.5 | 3.2 | · | 2.0 | 1.7 | 1.0 | · | 3.2 | · | |
| P / Tangible Book | 6.5 | 3.2 | · | 2.0 | 1.7 | 1.0 | · | 3.2 | · | |
| P / Cash Flow | · | -70.3 | · | · | · | -10.9 | · | · | · | |
| P / FCF | · | -68.8 | · | · | · | -10.9 | · | · | · | |
| Earnings Yield | -4.5% | -8.1% | · | -26.9% | -146.3% | -357.3% | · | -134.9% | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Nettoergebnis | $-87M | $-62M | $-33M |
| Verwässerte EPS | $-2.38 | $-5.82 | $-31.96 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Liquiditätsgrad | 24.6 | 24.2 | — |
| Quick Ratio | 24.1 | 23.7 | — |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Freier Cashflow | $-82M | $-56M | — |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 182 Einreicher · $2.7B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 47 (+14 vs. Vorquartal) | 18 (-1 vs. Vorquartal) | 59 (+20 vs. Vorquartal) | 47 (-3 vs. Vorquartal) | +4.5M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | $367.191.118 | 6.652.013 | 13,63% | Aktien |
| FMR LLC | $268.545.074 | 4.864.947 | 9,97% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $218.738.501 | 3.962.654 | 8,12% | Aktien |
| NEA Management Company, LLC | $199.519.627 | 3.614.486 | 7,41% | Aktien |
| ORBIMED ADVISORS LLC | $189.266.227 | 3.428.736 | 7,03% | Aktien |
| Paradigm Biocapital Advisors LP | $138.442.428 | 2.508.015 | 5,14% | Aktien |
| NVP ASSOCIATES, LLC | $117.925.692 | 2.136.335 | 4,38% | Aktien |
| Deep Track Capital, LP | $95.637.809 | 1.732.569 | 3,55% | Aktien |
| Polar Capital Holdings Plc | $88.789.973 | 1.608.514 | 3,30% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $81.551.818 | 1.477.388 | 3,03% | Aktien |
| Aaron Wealth Advisors LLC | $64.462.505 | 1.167.799 | 2,39% | Aktien |
| Driehaus Capital Management LLC | $58.323.161 | 1.056.579 | 2,17% | Aktien |
| Kynam Capital Management, LP | $51.600.905 | 934.799 | 1,92% | Aktien |
| Woodline Partners LP | $49.685.078 | 900.092 | 1,84% | Aktien |
| EVENTIDE ASSET MANAGEMENT, LLC | $48.216.758 | 873.492 | 1,79% | Aktien |
| STATE STREET CORP | $47.718.523 | 864.466 | 1,77% | Aktien |
| Parkman Healthcare Partners LLC | $44.169.550 | 800.173 | 1,64% | Aktien |
| BRAIDWELL LP | $39.240.576 | 710.880 | 1,46% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $36.875.889 | 667.870 | 1,37% | Aktien |
| TCG Crossover Management, LLC | $35.880.000 | 650.000 | 1,33% | Aktien |
| Cormorant Asset Management, LP | $30.360.000 | 550.000 | 1,13% | Aktien |
| Soleus Capital Management, L.P. | $28.443.401 | 515.279 | 1,06% | Aktien |
| MARSHALL WACE, LLP | $22.184.052 | 401.885 | 0,82% | Aktien |
| EcoR1 Capital, LLC | $21.445.200 | 388.500 | 0,80% | Aktien |
| GOLDMAN SACHS GROUP INC | $21.151.812 | 383.185 | 0,79% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $19.138.778 | 346.717 | 0,71% | Aktien |
| Rock Springs Capital Management LP | $16.461.634 | 298.218 | 0,61% | Aktien |
| Candriam S.C.A. | $15.986.698 | 289.893 | 0,59% | Aktien |
| BANK OF AMERICA CORP /DE/ | $15.871.325 | 287.524 | 0,59% | Aktien |
| Opaleye Management Inc. | $14.352.000 | 260.000 | 0,53% | Aktien |
| Schonfeld Strategic Advisors LLC | $13.726.583 | 248.670 | 0,51% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $12.866.844 | 233.095 | 0,48% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $12.527.364 | 226.945 | 0,47% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $12.483.535 | 226.151 | 0,46% | Aktien |
| Tetragon Partners GP Ltd | $11.235.574 | 203.543 | 0,42% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $11.118.881 | 201.429 | 0,41% | Aktien |
| Caption Management, LLC | $11.040.000 | 200.000 | 0,41% | Kaufoption |
| Caption Management, LLC | $11.040.000 | 200.000 | 0,41% | Verkaufsoption |
| Caligan Partners LP | $11.040.000 | 200.000 | 0,41% | Aktien |
| D. E. Shaw & Co., Inc. | $10.088.738 | 182.767 | 0,37% | Aktien |
| KVP Capital Advisors, LP | $6.708.125 | 121.524 | 0,25% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $6.263.820 | 113.475 | 0,23% | Aktien |
| Burkehill Global Management, LP | $5.520.000 | 100.000 | 0,20% | Aktien |
| TD Asset Management Inc | $5.277.010 | 95.598 | 0,20% | Aktien |
| VANGUARD GROUP INC | $5.248.193 | 166.398 | 0,19% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.210.880 | 94.400 | 0,19% | Kaufoption |
| Elmind Capital, LP | $5.023.200 | 91.000 | 0,19% | Aktien |
| BARCLAYS PLC | $4.755.424 | 86.149 | 0,18% | Aktien |
| Affinity Asset Advisors, LLC | $4.140.000 | 75.000 | 0,15% | Aktien |
| PFM Health Sciences, LP | $3.917.599 | 70.971 | 0,15% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $3.883.486 | 70.353 | 0,14% | Aktien |
| PRUDENTIAL FINANCIAL INC | $3.684.324 | 66.745 | 0,14% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $3.649.382 | 66.112 | 0,14% | Aktien |
| MOORE CAPITAL MANAGEMENT, LP | $3.582.094 | 64.893 | 0,13% | Aktien |
| Rhenman & Partners Asset Management AB | $3.422.400 | 62.000 | 0,13% | Aktien |
| BlackRock, Inc. | $2.806.534 | 50.843 | 0,10% | Aktien |
| ALPS ADVISORS INC | $2.650.262 | 48.012 | 0,10% | Aktien |
| PLATINUM INVESTMENT MANAGEMENT LTD | $2.406.554 | 43.597 | 0,09% | Aktien |
| Swiss National Bank | $2.368.080 | 42.900 | 0,09% | Aktien |
| Ensign Peak Advisors, Inc | $2.327.011 | 42.156 | 0,09% | Aktien |
| ALGERT GLOBAL LLC | $2.322.264 | 42.070 | 0,09% | Aktien |
| JANE STREET GROUP, LLC | $2.075.520 | 37.600 | 0,08% | Kaufoption |
| RHUMBLINE ADVISERS | $2.053.213 | 37.196 | 0,08% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.711.200 | 31.000 | 0,06% | Verkaufsoption |
| Bank of New York Mellon Corp | $1.627.958 | 29.492 | 0,06% | Aktien |
| WELLS FARGO & COMPANY/MN | $1.562.878 | 28.313 | 0,06% | Aktien |
| EXCHANGE TRADED CONCEPTS, LLC | $1.513.639 | 27.421 | 0,06% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.472.957 | 26.684 | 0,05% | Aktien |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $1.424.160 | 25.800 | 0,05% | Aktien |
| CITIGROUP INC | $1.287.871 | 23.331 | 0,05% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $1.251.936 | 22.680 | 0,05% | Aktien |
| CITADEL ADVISORS LLC | $1.236.480 | 22.400 | 0,05% | Kaufoption |
| AQR CAPITAL MANAGEMENT LLC | $1.215.007 | 22.011 | 0,05% | Aktien |
| Cerity Partners LLC | $1.149.374 | 20.822 | 0,04% | Aktien |
| Vanguard Global Advisers, LLC | $1.047.089 | 18.969 | 0,04% | Aktien |
| MetLife Investment Management, LLC | $1.007.400 | 18.250 | 0,04% | Aktien |
| Koa Wealth Management, LLC | $944.638 | 17.113 | 0,04% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $925.350 | 31.000 | 0,03% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $881.599 | 15.971 | 0,03% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $814.310 | 14.752 | 0,03% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $788.918 | 14.292 | 0,03% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $679.535 | 22.765 | 0,03% | Aktien |
| Invesco Ltd. | $679.015 | 12.301 | 0,03% | Aktien |
| DAFNA Capital Management LLC | $651.857 | 11.809 | 0,02% | Aktien |
| HighVista Strategies LLC | $642.197 | 11.634 | 0,02% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $607.200 | 11.000 | 0,02% | Aktien |
| FRED ALGER MANAGEMENT, LLC | $545.210 | 9.877 | 0,02% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $544.272 | 9.860 | 0,02% | Aktien |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $539.690 | 9.777 | 0,02% | Aktien |
| Virtus Investment Advisers, LLC | $508.668 | 9.215 | 0,02% | Aktien |
| China Universal Asset Management Co., Ltd. | $506.460 | 9.175 | 0,02% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $505.301 | 9.154 | 0,02% | Aktien |
| PROFUND ADVISORS LLC | $486.422 | 8.812 | 0,02% | Aktien |
| ACT CAPITAL MANAGEMENT, LLC | $441.600 | 8.000 | 0,02% | Aktien |
| Optimize Financial Inc | $433.064 | 14.508 | 0,02% | Aktien |
| DNB Asset Management AS | $430.174 | 7.793 | 0,02% | Aktien |
| AXQ CAPITAL, LP | $428.186 | 7.757 | 0,02% | Aktien |
| State of New Jersey Common Pension Fund D | $381.598 | 6.913 | 0,01% | Aktien |
| Quantinno Capital Management LP | $358.634 | 6.497 | 0,01% | Aktien |
| Rafferty Asset Management, LLC | $353.832 | 6.410 | 0,01% | Aktien |
Unternehmensinsider 22 Insider · 4 Führungskräfte · 10 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Steven L. Hoerter | President and CEO | 3. August 2026 A | 82.938 | 1 | 0 | $265.000 |
| Kent P. Hawryluk | President & CEO | 6. Mai 2026 S | 727.667 | 2 | 1 | $780.454 |
| John W Smither | Chief Financial Officer | 3. August 2026 A | 28.000 | 0 | 0 | $0 |
| Richard Bartram | Chief Financial Officer | 2. Februar 2026 A | 15.000 | 0 | 0 | $0 |
| Steven Ryder | Direktor | 4. Juni 2026 A | — | 0 | 0 | $0 |
| Tiba Aynechi | Direktor | 4. Juni 2026 A | 2.136.335 | 0 | 0 | $0 |
| Laurie Stelzer | Direktor | 4. Juni 2026 A | — | 0 | 0 | $0 |
| Ora H. Pescovitz | Direktor | 4. Juni 2026 A | 24.329 | 0 | 0 | $0 |
| Patrick J. Heron | Direktor | 4. Juni 2026 A | 4.552.774 | 0 | 0 | $0 |
| Edward T. Mathers | Direktor | 4. Juni 2026 A | 3.614.486 | 0 | 0 | $0 |
| James M Cornelius | Direktor | 5. Juni 2025 A | 102.082 | 0 | 0 | $0 |
| GORDON CARL L | Direktor | 18. Februar 2025 P | 747.887 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10%-Eigentümer | 16. September 2024 C | 1.790.122 | 0 | 0 | $0 |
| Rick Yang | 10%-Eigentümer | 16. September 2024 C | 3.614.486 | 0 | 0 | $0 |
| Carmen Chang | 10%-Eigentümer | 16. September 2024 C | 3.614.486 | 0 | 0 | $0 |
| Mohamad Makhzoumi | 10%-Eigentümer | 16. September 2024 C | 3.614.486 | 0 | 0 | $0 |
| Ali Behbahani | 10%-Eigentümer | 16. September 2024 C | 3.614.486 | 0 | 0 | $0 |
| Anthony A. Florence, Jr. | 10%-Eigentümer | 16. September 2024 C | 3.614.486 | 0 | 0 | $0 |
| Paul Walker | 10%-Eigentümer | 16. September 2024 C | 3.614.486 | 0 | 0 | $0 |
| Forest Baskett | 10%-Eigentümer | 16. September 2024 C | 3.614.486 | 0 | 0 | $0 |
| Scott D. Sandell | 10%-Eigentümer | 16. September 2024 C | 3.614.486 | 0 | 0 | $0 |
| Salomon Azoulay | — | 4. August 2026 S | 14.399 | 0 | 4 | $-2.716.674 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences X, L.P., FHMLS X, L.P., FHMLS X, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., James N. Topper, Patrick J. Heron ×4 Einreichungen | 10. August 2026 | 11,70% | Änderung | — | SEC |
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP VII LLC, ORBIMED GENESIS GP LLC ×4 Einreichungen | 10. August 2026 | 6,40% | Änderung | — | SEC |
| New Enterprise Associates 17, L.P., NEA Partners 17, L.P., NEA 17 GP, LLC, Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Edward T. Mathers, Scott D. Sandell, Paul Walker, Rick Yang ×2 Einreichungen | 10. November 2025 | 8,10% | Änderung | Passive Anlage | SEC |
| Norwest Venture Partners XVI, LP, Genesis VC Partners XVI, LLC, NVP Associates, LLC, Jeffrey Crowe, Jon Erik Kossow, Tiba Aynechi ×2 Einreichungen | 30. September 2025 | 4,80% | Änderung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 45 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 1,52% | 55.186 SH | 8. August 2026 | Täglich |
| PILL · Direxion Shares ETF Trust | 1,37% | 5.866 NS | 30. April 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 0,90% | 46.286 NS | 31. Mai 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,75% | 9.242 NS | 30. April 2026 | N-PORT |
| HRTS · Tema ETF Trust | 0,53% | 8.761 NS | 31. Mai 2026 | N-PORT |
| IWC · iShares Trust | 0,47% | 105.329 SH | 8. August 2026 | Täglich |
| IHE · iShares Trust | 0,39% | 95.133 SH | 8. August 2026 | Täglich |
| FMED · Fidelity Covington Trust | 0,39% | 5.128 NS | 31. Mai 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,22% | 2.591 SH | 8. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,19% | 67.904 SH | 8. August 2026 | Täglich |
| IBB · iShares Trust | 0,15% | 216.559 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,13% | 281.995 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,10% | 33.276 SH | 8. August 2026 | Täglich |
| FFSM · FIDELITY COVINGTON TRUST | 0,08% | 36.306 NS | 30. April 2026 | N-PORT |
| BIB · ProShares Trust | 0,07% | 1.658 NS | 31. Mai 2026 | N-PORT |
| IWM · iShares Trust | 0,07% | 784.502 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 178.613 SH | 8. August 2026 | Täglich |
| ISCV · iShares Trust | 0,03% | 3.348 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,03% | 12.353 NS | 30. April 2026 | N-PORT |
| ISCB · iShares Trust | 0,03% | 1.098 SH | 8. August 2026 | Täglich |
| GSSC · Goldman Sachs ETF Trust | 0,02% | 7.648 NS | 31. Mai 2026 | N-PORT |
| ITWO · ProShares Trust | 0,02% | 1.340 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 305.918 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,02% | 64.357 SH | 8. August 2026 | Täglich |
| ISCG · iShares Trust | 0,02% | 2.970 SH | 8. August 2026 | Täglich |
| SCHA · SCHWAB STRATEGIC TRUST | 0,02% | 119.833 NS | 31. Mai 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 1.376 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,01% | 1.048 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 10.305 NS | 30. April 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 1.060 NS | 31. Mai 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 40.965 NS | 30. April 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,01% | 5.970 NS | 31. Mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 1.397 NS | 31. Mai 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 14.062 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 27 NS | 31. Mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 41.133 SH | 8. August 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 7.686 SH | 8. August 2026 | Täglich |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 15.071 NS | 31. Mai 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 5.577 NS | 30. April 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 8.774 NS | 30. April 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 344 NS | 30. April 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 869 NS | 30. April 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.135.725 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.567 SH | 8. August 2026 | Täglich |
| DFSU · Dimensional ETF Trust | 0,00% | 29 NS | 30. April 2026 | N-PORT |